本文翻译正在准备中。在此之前,我们暂时显示英文原文。
监管与法律 · 2017/12/81 分钟阅读
Prospective Grant of Exclusive Patent License: N-Acetyl Mannosamine as a Therapeutic Agent
本地自动翻译 · 来源原始语言
摘要
The National Human Genome Research Institute, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patents and Patent Applications listed in the Supplementary Information section of this notice to Leadiant Biosciences, Inc, located in Gaithersburg, Maryland, USA.
来源原始语言: Federal Register — All Documents打开原始公告 →